Request Call Back

Contact Us

Risperdal
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Did you experience any of the following side effects?
(Please check all that apply.)






Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Risperdal

Risperdal Side Effects Lawsuits | Side Effects: Neuroleptic Malignant Syndrome (NMS), Stroke, Tardive Dyskinesia
We Are Presently Not Accepting Risperdal/Diabetes Cases
CLICK HERE TO DOWNLOAD OUR RISPERAL INFORMATION PACKAGE

Risperdal Side Effects May Lead To Stroke Lawsuits

Risperdal | Lawsuits, Lawyers | Side Effects: Neuroleptic Malignant Syndrome (NMS), Stroke, Tardive Dyskinesia

Risperdal (Generic: Risperidone) has been linked to Diabetes; prompting the FDA to request that Johnson and Johnson issue a warning to patients and prospective patients. In a recent study, Risperdal increased a patients chances of developing diabetes by about 50 percent compared with older antipsychotics.

Risperdal has also been linked to Neuroleptic Malignant Syndrome (NMS), Stroke and Tardive Dyskinesia. There have been 37 reports of stroke or stroke-like events, including 16 deaths linked to Risperdal. In April 2003, Johnson & Johnson sent warning letters to U.S. Physicians citing the drug’s elevated risk of stroke in elderly patients.

Neuroleptic Malignant Syndrome (NMS) is a potentially fatal syndrome involving muscle rigidity, and irregular blood pressure and irregular pulse. Tardive Dyskinesia is a central nervous system disorder, which results in involuntary movement of the limbs and twitching of the face and tongue. Risperdal is a medication that treats symptoms of Schizophrenia. Medications also know as conventional antipsychotics were originally introduced in the 1950s.

Risperdal is a newer atypical antipsychotic drug prescribed to help people combat Schizophrenia. Risperdal is manufactured by Jannsen Pharmaceuticals, a division of Johnson & Johnson. Risperdal has been known to cause irregular heartbeats, muscle weakness and spasms, high fever, constipation, weight gain and headaches. Schizophrenia is a serious mental illness that affects thousands of people everyday.

This illness results in the inability to manage emotions, make decisions and related to others. The American Psychiatric Association says that schizophrenia is “one of the most debilitating and baffling mental illnesses”. Schizophrenia is caused by an imbalance of chemicals in the brain. Stress, heredity, drugs, other medical illness and physical injury to the brain also can cause schizophrenia.

Dopamine and Serotonin are the two main imbalances of brain chemicals that cause this illness. Dopamine controls emotions, motivation and movement. Regulation of mood, sleep and appetite are controlled by Serotonin. An individual who suffers from Schizophrenia have abnormalities in Dopamine and Serotonin.

Legal Help For Victims Affected By Risperdal

If you or a loved one took Risperdal and suffered side effects, please fill out the form at the right for a free lawsuit case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).

For more information please visit Parker & Waichman, LLP's Risperdal Site at www.risperdaldiabetes.com

 

RisperdalRSS Feed

L'Oreal Faces Lawsuit Alleging Hair Relaxer Caused Baldness

Sep 19, 2016
Two women are suing L'Oréal over a hair relaxer that allegedly caused scalp burns and hair loss. The product claims to make hair "instantly thicker and fuller, reversing damage from day one," The product named in the lawsuit is Softsheen Carson Optimum Amla Legend Relaxer Kit. The relaxer is marketed as being "no-lye" and containing "Amla oil from India". The class action lawsuit was filed in Los Angeles. According to the complaint, the plaintiff suffered burns and subsequent scabs on...

Risperdal Award Increased Over Delay Damages

Sep 16, 2016
In a recent Risperdal (risperidone) gynecomastia lawsuit, a Pennsylvania judge has agreed to increase a $70 million award to over $76 million. The Risperdal gynecomastia lawsuit was filed against Johnson & Johnson's subsidiary, Janssen Pharmaceuticals, by a family on behalf of their teenage son. The boy, who took the antipsychotic drug Risperdal, allegedly began to develop breasts, a condition known as gynecomastia. The additional $6.7 million award is meant to cover delay damages, given...

Johnson & Johnson Said it's Near Risperdal Settlement with Feds, State

Aug 3, 2012 | Parker Waichman LLP
Johnson & Johnson has indicated that it has reached a settlement deal, in principle, with the U.S. Justice Department over charges it illegally marketed its anti-psychotic drug Risperdal. The two sides had been negotiating settlement terms over these charges and the Justice Dept. has previously rejected an offer from Johnson & Johnson to pay about $1 billion to cover the charges. Bloomberg News is reporting the settlement terms would likely have the pharmaceutical company pay $2.2...

J&J close to settlement on Risperdal illegal marketing charges

Jan 1, 2012 | Parker Waichman LLP
Wall Street Journal reports that Johnson & Johnson is nearing a settlement agreement on federal charges that it illegally marketed its schizophrenia drug Risperdal. The settlement is believed to range between $1.5 and $1.7 billion.  Dept. of Justice prosecutors have been pursuing illegal marketing charges against Johnson & Johnson for encouraging physicians and other health care professionals to dispense Risperdal for indications other than what it is approved to treat. The...

Feds Say Kickbacks Paid to Increase use of Risperdal, Levaquin at Omnicare Nursing Home Change

Jan 18, 2010 | Parker Waichman LLP
Johnson & Johnson has been charged with paying kickbacks to the Omnicare nursing home chain in order to increase the use of its drugs at the chain's homes.  While Johnson & Johnson was allegedly paying kickbacks, federal prosecutors claim that Omnicare’s annual purchases of the company's drugs, including Risperdal and Levaquin,  nearly tripled to more than $280 million.In November, Omnicare agreed to pay $98 million to settle charges related to the alleged Johnson &...

More Risperdal News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo